PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Harnessing the power of a parasite that can stop pain

Study reveals pain-relief pathways in disfiguring skin disease

2023-11-30
(Press-News.org) COLUMBUS, Ohio – For the first time, scientists have begun to figure out why the disfiguring skin lesions caused by cutaneous leishmaniasis don’t hurt.

Researchers analyzed leishmaniasis lesions on mouse skin to detect metabolic signaling pathways that differed from uninfected mice. Results suggested the parasites that cause the disease change pain perception – presumably as a way to delay treatment and promote their own survival.

“No one knows why these lesions are painless – but it has been thought that the parasite somehow manipulates the host physiological system,” said Abhay Satoskar, senior author of the study and professor of pathology in The Ohio State University College of Medicine.

“Based on our data, something the parasites do triggers pathways that suppress pain. How they do that, we’re still investigating.”

Beyond increasing understanding of this parasitic disease afflicting 1 million new patients each year, the research could lead to development of new non-narcotic pain medications.

“We hypothesize that any molecules the parasite’s presence is producing could be potential painkillers for other health problems,” Satoskar said.

The study was published recently in the journal iScience.

The lack of pain in leishmaniasis lesions has puzzled scientists for years, especially when similar blisters caused by conditions like chicken pox, staphylococcus infections or the herpes virus are itchy, oozy and sore.

After giving mice chronic infections with Leishmania mexicana, the species that causes cutaneous leishmaniasis in South, Central and North America, researchers used an unbiased mass spectrometry analysis of the lesions to identify molecules known to be associated with pain suppression.

They found numerous metabolites – products of bio-chemical reactions that break down food to produce energy and perform other essential functions – that have been linked in previous research to blockage of pain perception. They also found pathways with pain-relief properties tied to the brain’s endocannabinoid system, which is involved in a host of physiological processes, including the pain response.

Cell-culture experiments in infected macrophages, the immune cells in which Leishmania parasites live, showed an increase in most, but not all, of the same changes as in the lesions.

The parasites use these metabolites as nutrition to help them replicate. But finding that certain pain-suppression pathways aren’t increased in infected macrophages leaves some questions unanswered, said Satoskar, also a professor of microbiology at Ohio State. 

“The infection does something in the cell that could be a direct or indirect effect – we don’t know. But the environment that the infection creates leads to production of these metabolites,” he said. “The exciting thing is that this is the first time we’ve begun to understand the cellular basis of why there is no pain in these lesions.

“The next key question is, if we know these pathways are responsible, then how are they triggered? By the parasite, or something the parasite is doing to the host cell, or a combination of both? There could be a lot of things happening.”

Skin test for immunity to Leishmania­-caused diseases

Satoskar has also co-led an initiative to develop a standardized skin test to check for immunity to Leishmania donovani, the parasite that causes visceral leishmaniasis – a potentially lethal form of the disease that affects the organs and is fatal if untreated.

He and colleagues recently reported in Nature Communications on this work, which is critical for disease surveillance in the most affected regions of the world and will be needed for phase 3 clinical trials of leishmaniasis vaccines the team has developed.

The test, using an antigen called leishmanin, is similar to a skin test for tuberculosis – a positive response means a person has been exposed to the parasite and has cellular immunity that prevents further clinical symptoms.

No tests or reagents are available to detect sporadic cases of leishmaniasis reported in the southern United States, so the skin test being developed will facilitate surveillance studies to assess exposure throughout the endemic regions for leishmaniasis – which include the U.S.

“This is a very important test in the field to understand who is exposed to this disease or not,” Satoskar said. “For many stakeholders going into a community to conduct surveillance, knowing who is immune and who is not immune is essential so they can deploy their limited resources appropriately for disease control.”

Leishmanin skin tests have existed and been in use in past years but are no longer available. This research team developed the antigen following Good Laboratory Practice guidelines and tested it in hamsters, a model for human visceral leishmaniasis, to ensure the skin test triggers the expected immune response to both infection and vaccination.

“This kind of data can be used for fast-track approval for Leishmania vaccines which are under development. We anticipate fulfilling the need of the entire global community,” Satoskar said.

Co-lead authors of the Nature Communications paper were Sanjay Singh of Gennova Biopharmaceuticals, Shinjiro Hamano of Nagasaki University, Sreenivas Gannavaram and Hira Nakhasi of the Food and Drug Administration, Greg Matlashewski of McGill University, and Shaden Kamhawi and Jesus Valenzuela of the National Institute of Allergy and Infectious Diseases (NIAID).

The Nature Communications work was supported by the Global Health Innovative Technology Fund, the Canadian Institutes of Health Research, the FDA, the National Institutes of Health, NAIAD and the Fonds de recherche du Quebec-Sante.

Nakhasi, Gannavaram and Nazli Azodi of the FDA also co-authored the iScience paper along with co-authors Greta Volpedo, Blake Cox, Yulian Mercado, Candice Askwith, and Matthew Bernier of Ohio State and Timur Oljuskin of the U.S. Department of Agriculture.

The iScience study was supported by the Metabolomics Workbench/National Metabolomics Data Repository, Common Fund Data Ecosystem and Metabolomics Consortium Coordinating Center.

#

Contact: Abhay Satoskar, Abhay.Satoskar@osumc.edu

Written by Emily Caldwell, Caldwell.151@osu.edu; 614-292-8152

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Aging modulates extracellular vesicles of epidermal keratinocytes

Aging modulates extracellular vesicles of epidermal keratinocytes
2023-11-30
“In this article, we describe for the first time the impact of chronological aging on EVs production by human keratinocytes.” BUFFALO, NY- November 30, 2023 – A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 22, entitled, “Chronological aging impacts abundance, function and microRNA content of extracellular vesicles produced by human epidermal keratinocytes.” The disturbance of intercellular communication is one of the hallmarks of aging. In their new study, researchers ...

Center for BrainHealth publishes new model to predict improvement in brain health

Center for BrainHealth publishes new model to predict improvement in brain health
2023-11-30
As part of its ongoing quest to advance better brain health and performance, new research led by Center for BrainHealth at The University of Texas at Dallas investigated neural biomarkers associated with improvements on a brain health index. The study, “Toward Precision Brain Health: Accurate Prediction of a Cognitive Index Trajectory Using Neuroimaging Metrics,” was recently published in Cerebral Cortex A total of 48 participants aged 21–65 completed a simple task during a functional magnetic resonance imaging (fMRI) session, then once ...

Scientists find gene therapy reduces liver cancer in animal model

2023-11-30
Researchers at UC Davis Comprehensive Cancer Center have shown that inhibiting a specific protein using gene therapy can shrink hepatocellular carcinoma (HCC) in mice. Silencing the galectin 1 (Gal1) protein, which is often over-expressed in HCC, also improved the anti-cancer immune response and increased the number of killer T cells inside tumors. The study was published in Acta Pharmaceutica Sinica B. “We’ve long known that Gal1 is a biomarker for hepatocellular carcinoma,” said ...

Air Force awards UTEP Grant to safeguard assets in space

Air Force awards UTEP Grant to safeguard assets in space
2023-11-30
EL PASO, Texas (Nov. 30, 2023) – Space near earth is teeming with objects, whether natural, like meteors and comets, or manmade, like satellites, spacecraft and rocket debris. But experts still need a clearer picture of the location and state of these objects, which can threaten space-based assets, such as GPS, weather-monitoring and communication satellites. “The United States is dependent economically and militarily on space assets,” said Miguel Velez-Reyes, Ph.D., chair of the Electrical and Computer Engineering Department at The University of Texas at El Paso. “For ...

Stigmatizing content on social media affects perceptions of mental health care, new study reveals

2023-11-30
Research has shown that social media can negatively impact people's mental health. But can it affect people’s beliefs about mental health treatment? Yes, according to researchers at Union. In one of the first studies to examine the impact of social media on people’s perceptions of mental health care, researchers discovered that viewing just a few social media posts that mock mental health treatment can have a profound impact on some people's attitudes toward treatment. The study appears in the latest issue of the journal Social Media + Society. For the study, 186 participants viewed 10 tweets. The gender ...

New study offers cautious hope about the resilience of redwoods

2023-11-30
New research from Northern Arizona University has explained coast redwood’s remarkable ability to recover from very severe fire, a rare sign of optimism amid a landscape increasingly scarred by severe fires. The study, published today in Nature: Plants, examined recovery after the catastrophic CZU Lightning Complex Fire, which began in August 2020 and burned thousands of acres of redwoods in Big Basin State Park in California, some more than 1,500 years old. Researchers from NAU’s Center for Ecosystem Science and Society (Ecoss) and the School of Informatics, Computing, and Cyber Systems (SICCS) found, however, that many trees were not dead, as they first appeared. Redwoods ...

The American Institute of Biological Sciences aannounces winner of the IDEAL Leadership Award

2023-11-30
The American Institute of Biological Sciences is pleased to announce Dr. Nyeema C. Harris as the 2023 winner of its Inspiring Inclusivity, Diversity, Equity, Acceptance, and Learning (IDEAL) Leadership Award. The IDEAL Award recognizes commendable leadership in advancing inclusion, diversity, equity, acceptance, accessibility, and learning in the biological sciences community. The award was presented by past awardee Dr. Steward T. A. Pickett on 30 November 2023 at AIBS's Council of Member Societies and Organizations meeting, entitled "Expanding the ...

Thomas Fire research reveals that ash can fertilize the oceans

2023-11-30
(Santa Barbara, Calif.) — Flames roared through Santa Barbara County in late 2017. UC Santa Barbara canceled classes, and the administration recommended donning an N95, long before the COVID pandemic made the mask a household item. Smoke and ash choked the air, but the Thomas Fire’s effects weren’t restricted to the land and sky. Huge amounts of ash settled into the oceans, leaving researchers to wonder what effect it might have on marine life. Now scientists at UC Santa Barbara have discovered that wildfire ash adds nutrients to marine systems, ...

Study tests firefighter turnout gear with, without PFAS

Study tests firefighter turnout gear with, without PFAS
2023-11-30
Transitioning away from per- and polyfluoroalkyl substances (PFAS), which offer water- and oil-repelling properties on the outer shells of firefighter turnout gear, could bring potential performance tradeoffs, according to a new study from North Carolina State University. The study showed that turnout gear without PFAS outer shell coatings were not oil-repellent, posing a potential flammability hazard to firefighters if exposed to oil and flame, said Bryan Ormond, assistant professor of textile engineering, chemistry and science at NC State and corresponding author of ...

New study uses genetic data to support use of thiazide diuretics for kidney stone prevention

New study uses genetic data to support use of thiazide diuretics for kidney stone prevention
2023-11-30
Kidney stones affect nearly 10% of the global population. For more than three decades, thiazide diuretics, a common medication used for high blood pressure, have been the standard of care for kidney stone prevention because they reduce the excretion of urinary calcium.     However, recent clinical trials have raised doubts about their efficacy in preventing kidney stones. The NOSTONE trial, published in The New England Journal of Medicine in March 2023, failed to find a protective effect of thiazide diuretics on kidney stone disease.     A ...

LAST 30 PRESS RELEASES:

Twelve questions to ask your doctor for better brain health in the new year

Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes

Study identifies genetic cause for yellow nail syndrome

New drug to prevent migraine may start working right away

Good news for people with MS: COVID-19 infection not tied to worsening symptoms

Department of Energy announces $179 million for Microelectronics Science Research Centers

Human-related activities continue to threaten global climate and productivity

Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

Unraveling the power and influence of language

Gene editing tool reduces Alzheimer’s plaque precursor in mice

TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies

Twisted Edison: Bright, elliptically polarized incandescent light

Structural cell protein also directly regulates gene transcription

Breaking boundaries: Researchers isolate quantum coherence in classical light systems

Brain map clarifies neuronal connectivity behind motor function

Researchers find compromised indoor air in homes following Marshall Fire

Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality

Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology

'Glass fences' hinder Japanese female faculty in international research, study finds

Vector winds forecast by numerical weather prediction models still in need of optimization

New research identifies key cellular mechanism driving Alzheimer’s disease

Trends in buprenorphine dispensing among adolescents and young adults in the US

Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility

Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity

Association of state cannabis legalization with cannabis use disorder and cannabis poisoning

Gestational hypertension, preeclampsia, and eclampsia and future neurological disorders

Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals

Unlocking the mysteries of the human gut

High-quality nanodiamonds for bioimaging and quantum sensing applications

New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia

[Press-News.org] Harnessing the power of a parasite that can stop pain
Study reveals pain-relief pathways in disfiguring skin disease